Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations

The estimated probability of progressing from phase 3 analgesic clinical trials to regulatory approval is approximately 57%, suggesting that a considerable number of treatments with phase 2 trial results deemed sufficiently successful to progress to phase 3 do not yield positive phase 3 results. Def...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pain
Egile Nagusiak: Gewandter, Jennifer S., Dworkin, Robert H., Turk, Dennis C., Devine, Eric G., Hewitt, David, Jensen, Mark P., Katz, Nathaniel P., Kirkwood, Amy A., Malamut, Richard, Markman, John D., Vrijens, Bernard, Burke, Laurie, Campbell, James N., Carr, Daniel B., Conaghan, Philip G., Cowan, Penney, Doyle, Mittie K., Edwards, Robert R., Evans, Scott R., Farrar, John T., Freeman, Roy, Gilron, Ian, Juge, Dean, Kerns, Robert D., Kopecky, Ernest A., McDermott, Michael P., Niebler, Gwendolyn, Patel, Kushang V., Rauck, Richard, Rice, Andrew S.C., Rowbotham, Michael, Sessler, Nelson E., Simon, Lee S., Singla, Neil, Skljarevski, Vladimir, Tockarshewsky, Tina, Vanhove, Geertrui F., Wasan, Ajay D., Witter, James
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7292738/
https://ncbi.nlm.nih.gov/pubmed/31843583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpain.2019.12.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak